Continuous Monitoring

We conduct ongoing international monitoring of endocrine disruptors in cosmetics and perfumes.

Each week, we publish scientific studies, public health agency opinions, investigative journalism, and international regulatory decisions.

This monitoring helps track the evolution of scientific knowledge and ensures that health warnings are not ignored or forgotten.

UV Filters: From Human Exposure to Environmental Endocrine Disruption

Endocrine disruptors are substances capable of interfering with hormonal signalling, potentially affecting growth, reproduction, metabolism, or development. In our previous article, we followed sunscreen UV filters from our skin to rivers, lakes, and oceans. But their journey doesn’t end there. Once these chemicals enter aquatic ecosystems, they continue interacting with living organisms and growing evidence […]

UV Filters: From Human Exposure to Environmental Endocrine Disruption Read Post »

LVMH and Endocrine Disruptors: When Scientific Evidence Moves Faster Than Regulation

Luxury brands rarely communicate about endocrine disruptors. Instead, they talk about innovation, excellence, sustainability and product safety. LVMH is no exception. Through its LIFE 360 environmental programme, the world’s leading luxury group presents itself as a company that places scientific expertise, ingredient safety and environmental responsibility at the heart of product development. Its public commitments

LVMH and Endocrine Disruptors: When Scientific Evidence Moves Faster Than Regulation Read Post »

UPDATE #7 – Still No Response: Tracking Industry Accountability

Since our previous update, we have continued contacting additional decision-makers across the cosmetics and luxury sectors regarding the presence of endocrine disruptors in consumer products and the industry’s responsibility to address these concerns transparently. To date, we have not received substantive responses. Again, silence persists. And frankly, this silence is increasingly difficult to understand. The

UPDATE #7 – Still No Response: Tracking Industry Accountability Read Post »

UPDATE #6 – Tracking Transparency: Chanel Decision-Makers Added to the List

We said we would keep tracking. We meant it. Since our previous update, we have continued contacting additional decision-makers across the cosmetics and luxury sectors regarding the presence of endocrine disruptors in consumer products and the industry’s responsibility to address these concerns transparently. To date, we have not received substantive responses. Again, silence persists. And

UPDATE #6 – Tracking Transparency: Chanel Decision-Makers Added to the List Read Post »

Update 5 : No Response from Chanel. Our Campaign Continues

Following our previous outreach to L’Oréal, LVMH, and Hermès regarding the presence of endocrine-disrupting substances in cosmetic products, we have continued this campaign by contacting Chanel. To date, we have received no response. Once again, despite the seriousness of the concerns raised, despite the scientific evidence available, and despite the public health implications involved, silence

Update 5 : No Response from Chanel. Our Campaign Continues Read Post »

Endocrine Disruptors : Why Regulation Is Still Struggling to Protect Consumers

Endocrine disruptors have become a major issue in environmental health discussions. Found in certain plastics, pesticides, cosmetics, textiles, and food packaging, these chemical substances can interfere with the body’s hormonal system and potentially affect human health. Over the past two decades, scientific publications on the subject have increased significantly. Yet regulation continues to move slowly,

Endocrine Disruptors : Why Regulation Is Still Struggling to Protect Consumers Read Post »

Why Regulating Endocrine Disruptors Is So Difficult: The Case of Hawaii

In recent decades, growing scientific evidence has raised concerns about endocrine disruptors, chemical substances capable of interfering with hormonal systems and potentially affecting development, reproduction, and long-term health outcomes (WHO/UNEP, 2013). Despite increasing awareness, regulating these substances remains a complex and politically sensitive challenge. The case of Hawaii provides a particularly illustrative example. A Landmark

Why Regulating Endocrine Disruptors Is So Difficult: The Case of Hawaii Read Post »

Scroll to Top